Aridis Pharmaceuticals Inc (ARDS)

$0.00 0.00 (N/A)
Market Cap 5,000.00
Revenue (ttm) 3.09M
Net Income (ttm) -30.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -982.85%
Debt to Equity Ratio 0.00
Volume 2,752
Avg Vol 23,560
Day's Range N/A - N/A
Shares Out 53.32M
Stochastic %K 50%
Beta 49.95
Analysts Strong Buy
Price Target $2.00

Company Profile

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquir...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 385 1742
Fax: 408 356 9548
Address:
983 University Avenue, Building B, Los Gatos, United States
Bigos
Bigos Aug. 24 at 11:35 PM
$ARDS You guys make too may excuses for Aridis management. The fact is that, after Vu had previously promoted the company and its prospects to investors, management ultimately allowed the company to lose its Nasdaq listing and thereafter failed to take the steps necessary to restore a normal public trading market for shareholders. Management then made the VOLUNTARY decision to stop maintaining the company’s SEC reporting compliance. Management itself acknowledged that this “VOLUNTAR NON-COMPLIANCE” caused ARDS to be moved to the OTC Expert Market, severely impairing liquidity and ordinary shareholders’ ability to trade their shares. Management also liquidated company equipment, office furniture, and other office inventory, apparently as part of winding down the company’s physical operations WITHOUT providing shareholders any meaningful public explanation of what was being sold, why it was being sold, how much was received, or what happened to the proceeds. No excuses should be made...
2 · Reply
Bigos
Bigos Jul. 19 at 10:47 PM
$ARDS That is @BuyoutBobby you are referring to. One minute he claimed he was going to travel from Deustchland and file a lawsuit against ARDS for choosing to delist from the markets. Then he said a buyout was imminent because he had "insider informations", and he was going to ten times his Deustche Marks investment and become a bazillionaire. But he has mostly dropped the bravado and seems to have sold all his ARDS shares.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Jul. 18 at 10:59 AM
$ARDS There was a guy who used to post here for years, talking about he was going to go after the CEO for this and that. I wonder what ever became of him or how successful he was. As far as I can tell, the company is still worth zero just like our investments.
0 · Reply
Bigos
Bigos Jul. 14 at 4:56 PM
$ARDS Even @BuyoutBobby thinks this one is completely dead. Vu can't even find a merger partner, or do a buyout to some other small biotech.
0 · Reply
PenkeInvesting
PenkeInvesting Jun. 28 at 5:10 AM
Fundamental analysis of $ARDS (Aridis Pharmaceuticals, Inc.) based on financial data and reported results. #ARDS #Aridis
0 · Reply
Shanenobody
Shanenobody Jun. 18 at 8:42 PM
$ARDS I wouldn't pay any attention to Buyout Bobby. Buyout Bobby thinks he has me blocked. Buyout Bobby wrote: "those articles don't mean much. They are published all the time." This is the first article posted on ARDS in a long, long time.
0 · Reply
BuyoutBobby
BuyoutBobby Jun. 17 at 7:54 PM
$ARDS there was a big trade today.
2 · Reply
Shanenobody
Shanenobody Jun. 14 at 5:56 PM
$ARDS Check the date at the bottom of this filing: https://www.sec.gov/Archives/edgar/data/1614067/000117266126002121/xslSCHEDULE_13G_X02/primary_doc.xml
0 · Reply
Shanenobody
Shanenobody Jun. 9 at 8:31 PM
$ARDS https://finance.yahoo.com/sectors/healthcare/articles/pneumonia-market-set-witness-robust-140100395.html
0 · Reply
Kess123
Kess123 May. 29 at 4:24 AM
$ARDS if you plan to sue, the window is closing: Filing a Civil Lawsuit (Securities Fraud) If you believe the company or its executives misled investors and you are looking to join or initiate a civil lawsuit to recover funds, the legal windows are much tighter. The 2-Year / 5-Year Rule: Under the Securities Exchange Act, civil lawsuits for securities fraud must be filed within 2 years after you discover the facts constituting the violation. The Statute of Repose: There is a hard legal cap of 5 years after the actual violation occurred, regardless of when you discovered the fraud. Once that 5-year mark hits, the liability is extinguished. Criminal Prosecution: For context, if the federal government (DOJ) pursues the company, they have a 6-year statute of limitations to bring criminal securities fraud charges.
2 · Reply
Latest News on ARDS
No data available.
Bigos
Bigos Aug. 24 at 11:35 PM
$ARDS You guys make too may excuses for Aridis management. The fact is that, after Vu had previously promoted the company and its prospects to investors, management ultimately allowed the company to lose its Nasdaq listing and thereafter failed to take the steps necessary to restore a normal public trading market for shareholders. Management then made the VOLUNTARY decision to stop maintaining the company’s SEC reporting compliance. Management itself acknowledged that this “VOLUNTAR NON-COMPLIANCE” caused ARDS to be moved to the OTC Expert Market, severely impairing liquidity and ordinary shareholders’ ability to trade their shares. Management also liquidated company equipment, office furniture, and other office inventory, apparently as part of winding down the company’s physical operations WITHOUT providing shareholders any meaningful public explanation of what was being sold, why it was being sold, how much was received, or what happened to the proceeds. No excuses should be made...
2 · Reply
Bigos
Bigos Jul. 19 at 10:47 PM
$ARDS That is @BuyoutBobby you are referring to. One minute he claimed he was going to travel from Deustchland and file a lawsuit against ARDS for choosing to delist from the markets. Then he said a buyout was imminent because he had "insider informations", and he was going to ten times his Deustche Marks investment and become a bazillionaire. But he has mostly dropped the bravado and seems to have sold all his ARDS shares.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Jul. 18 at 10:59 AM
$ARDS There was a guy who used to post here for years, talking about he was going to go after the CEO for this and that. I wonder what ever became of him or how successful he was. As far as I can tell, the company is still worth zero just like our investments.
0 · Reply
Bigos
Bigos Jul. 14 at 4:56 PM
$ARDS Even @BuyoutBobby thinks this one is completely dead. Vu can't even find a merger partner, or do a buyout to some other small biotech.
0 · Reply
PenkeInvesting
PenkeInvesting Jun. 28 at 5:10 AM
Fundamental analysis of $ARDS (Aridis Pharmaceuticals, Inc.) based on financial data and reported results. #ARDS #Aridis
0 · Reply
Shanenobody
Shanenobody Jun. 18 at 8:42 PM
$ARDS I wouldn't pay any attention to Buyout Bobby. Buyout Bobby thinks he has me blocked. Buyout Bobby wrote: "those articles don't mean much. They are published all the time." This is the first article posted on ARDS in a long, long time.
0 · Reply
BuyoutBobby
BuyoutBobby Jun. 17 at 7:54 PM
$ARDS there was a big trade today.
2 · Reply
Shanenobody
Shanenobody Jun. 14 at 5:56 PM
$ARDS Check the date at the bottom of this filing: https://www.sec.gov/Archives/edgar/data/1614067/000117266126002121/xslSCHEDULE_13G_X02/primary_doc.xml
0 · Reply
Shanenobody
Shanenobody Jun. 9 at 8:31 PM
$ARDS https://finance.yahoo.com/sectors/healthcare/articles/pneumonia-market-set-witness-robust-140100395.html
0 · Reply
Kess123
Kess123 May. 29 at 4:24 AM
$ARDS if you plan to sue, the window is closing: Filing a Civil Lawsuit (Securities Fraud) If you believe the company or its executives misled investors and you are looking to join or initiate a civil lawsuit to recover funds, the legal windows are much tighter. The 2-Year / 5-Year Rule: Under the Securities Exchange Act, civil lawsuits for securities fraud must be filed within 2 years after you discover the facts constituting the violation. The Statute of Repose: There is a hard legal cap of 5 years after the actual violation occurred, regardless of when you discovered the fraud. Once that 5-year mark hits, the liability is extinguished. Criminal Prosecution: For context, if the federal government (DOJ) pursues the company, they have a 6-year statute of limitations to bring criminal securities fraud charges.
2 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 12 at 10:01 PM
$ARDS Anything new? Like an old ghost town around here. I can almost hear the squeaking doors moving in the wind. It sure blew away our money like tumbleweeds. Nothing left but a lonely empty shell now. Shoulda been. Coulda been. Woulda been. Hey, let's not kid ourselves, we were robbed like a Jessie James holdup. Make no bones about it.
1 · Reply
CNPPLC
CNPPLC May. 6 at 2:41 PM
$ARDS If the state filing is delinquent., the shareholders can takeover the company under state law and bring the OTC listing to full compliance.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 1 at 1:45 AM
$ARDS My smallest checking account has more money than the entire market cap of this stock. Who works there? Volunteers?
2 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 29 at 5:07 AM
$ARDS I was really disappointed on how this stock played out. I expected it to be some short gold mine or something. A diamond in the rough. It turned out to be just a hard road apple.
1 · Reply
BuyoutBobby
BuyoutBobby Apr. 14 at 7:54 PM
$ARDS they published a news on their website. Maybe its not over yet.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 10 at 10:50 AM
$ARDS I bought this stock years ago and still holding on tho WORTHLESS shares. Has anyone heard any news on it? Anything? Is it completely dead?
1 · Reply
Bigos
Bigos Mar. 16 at 6:35 PM
$ARDS @BuyoutBobby @Shanenobody If Vu had any kind of ethics / belief in the company technology, he would seek a merger with a related, small biotech company, or would look to sell the whole thing on the cheap to someone else. The fact that he hasn't says a whole lot.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Mar. 15 at 1:21 AM
$ARDS
0 · Reply
Shanenobody
Shanenobody Feb. 27 at 8:39 PM
$ARDS So BuyoutBobby exactly when are you going to make sure AstraZeneca's reputation is damaged.
1 · Reply
Shanenobody
Shanenobody Feb. 27 at 8:33 PM
$ARDS
2 · Reply
BuyoutBobby
BuyoutBobby Feb. 26 at 7:15 PM
$ARDS Armistice is still holding their shares.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Feb. 21 at 2:45 AM
$ARDS @Phaaisatroll that buyout/partnership sure is taking a long time, you lying sack of turds.
1 · Reply